Values First Advisors, Inc. Royalty Pharma PLC Transaction History
Values First Advisors, Inc.
- $177 Million
- Q4 2024
A detailed history of Values First Advisors, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Values First Advisors, Inc. holds 15,963 shares of RPRX stock, worth $500,120. This represents 0.23% of its overall portfolio holdings.
Number of Shares
15,963
Previous 10,412
53.31%
Holding current value
$500,120
Previous $294,000
38.44%
% of portfolio
0.23%
Previous 0.16%
Shares
6 transactions
Others Institutions Holding RPRX
# of Institutions
414Shares Held
282MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.29 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1.18 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$721 Million0.01% of portfolio
-
Baillie Gifford & CO14.1MShares$443 Million0.28% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$381 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...